COVID-19 Conversation: Dr. David Carbone, April 6, 2020

LUNGevity spoke with David Carbone, MD, PhD, who answered several questions about COVID-19 and lung cancer trials and infusion-related treatments from his perspective as a medical oncologist at The Ohio State University. It is important to note that the conversation took place on April 6, as issues around the COVID-19 pandemic can change rapidly.

The questions Dr. Carbone addressed fall into four categories:

  • Clinical trials
  • Infusion-related treatments (immunotherapy)
  • Infusion-related treatments (chemotherapy)
  • General message to the community

You can download a transcript of Dr. Carbone's responses here (respuestas en español aquí).